Bioequivalence standards for generic drugs have long ignored batch-to-batch variability, risking false conclusions. New guidelines now require multi-batch testing to ensure real-world equivalence and patient safety.
Apr, 9 2026
Sep, 28 2025
Jan, 7 2026
Dec, 7 2024
Jun, 8 2026